News
Tourmaline Bio is a clinical-stage biopharmaceutical company developing pacibekitug, an anti-IL-6 mAb, as a treatment option for atherosclerotic cardiovascular disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback